Skip to main content

An innovative & seamless approach for the mass spectrometry analysis of monoclonal antibodies

Project description

Streamlining innovation with automated production of highly selective immunotherapies

The immune system is a complex team that targets and destroys pathogens and helps your body eliminate damaged or abnormal cells such as cancer cells. Antibodies attach themselves to antigens, markers on the surface of targeted cells, letting other players know to come to the rescue. Monoclonal antibodies (MAbs) are laboratory-produced antibodies with very high specificity made by fusing antibody-producing cells with an immortal cell line. Although the types of MAbs available are rapidly increasing, the separation process to ensure purity is still done manually. iSTantibody is revolutionising this process with an automated platform that promises to drastically reduce production time as well as free up highly skilled scientists to research and develop even more therapies.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

PREOMICS GMBH
Net EU contribution
€ 50 000,00
Address
Am Klopferspitz 19
82152 Planegg Martinsried
Germany

See on map

Region
Bayern Oberbayern München, Landkreis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00